Session

IBD (Posters)

IMPACT OF PRIOR TUMOUR NECROSIS FACTOR INHIBITOR FAILURE AND PRIOR CORTICOSTEROID USE ON THE MAINTENANCE OF EFFICACY OF TOFACITINIB FOLLOWING DOSE REDUCTION IN PATIENTS WITH ULCERATIVE COLITIS WHO WERE IN STABLE REMISSION: 6-MONTH DATA FROM THE DOUBLE-BLI
IMPACT OF PRIOR TUMOUR NECROSIS FACTOR INHIBITOR FAILURE AND PRIOR CORTICOSTEROID USE ON THE MAINTENANCE OF EFFICACY OF TOFACITINIB FOLLOWING DOSE REDUCTION IN PATIENTS WITH ULCERATIVE COLITIS WHO WERE IN STABLE REMISSION: 6-MONTH DATA FROM THE DOUBLE-BLI

IBD (Posters)  et al.

ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME
ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

IBD (Posters)  et al.

ASSOCIATION BETWEEN EFFICACY OUTCOMES AND PRIOR DURATION OF REMISSION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB 10 MG TWICE DAILY (BID) WHO WERE IN STABLE REMISSION AND DOSE-REDUCED TO 5 MG BID OR REMAINED ON 10 MG BID: 6-MONTH DATA FRO
ASSOCIATION BETWEEN EFFICACY OUTCOMES AND PRIOR DURATION OF REMISSION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB 10 MG TWICE DAILY (BID) WHO WERE IN STABLE REMISSION AND DOSE-REDUCED TO 5 MG BID OR REMAINED ON 10 MG BID: 6-MONTH DATA FRO

IBD (Posters)  et al.

VACCINATION STRATEGIES IN INFLAMMATORY BOWEL DISEASE PATIENTS: PERSPECTIVE OF PHYSICIANS AND PATIENTS.
VACCINATION STRATEGIES IN INFLAMMATORY BOWEL DISEASE PATIENTS: PERSPECTIVE OF PHYSICIANS AND PATIENTS.

IBD (Posters)  et al.

ADHERENCE TO VACCINATION RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE PATIENT: A LONG WAY FOR IMPROVING.
ADHERENCE TO VACCINATION RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE PATIENT: A LONG WAY FOR IMPROVING.

IBD (Posters)  et al.

SARS-COV-2 VACCINE ACCEPTANCE AMONG GASTROENTEROLOGIST AND INFLAMMATORY BOWEL DISEASE PATIENTS: VACUNEII PROJECT
SARS-COV-2 VACCINE ACCEPTANCE AMONG GASTROENTEROLOGIST AND INFLAMMATORY BOWEL DISEASE PATIENTS: VACUNEII PROJECT

IBD (Posters)  et al.

USTEKINUMAB FOR ULCERATIVE COLITIS A REAL-WORLD EXPERIENCE - RETROSPECTIVE DATA ANALYSIS OF THE IBD COHORT ORDENSKLINIKUM LINZ
USTEKINUMAB FOR ULCERATIVE COLITIS A REAL-WORLD EXPERIENCE - RETROSPECTIVE DATA ANALYSIS OF THE IBD COHORT ORDENSKLINIKUM LINZ

IBD (Posters)

DEFINITION OF A MICROBIAL SIGNATURE AS A PREDICTOR OF POST-SURGICAL RECURRENCE IN PATIENTS WITH CROHN'S DISEASE
DEFINITION OF A MICROBIAL SIGNATURE AS A PREDICTOR OF POST-SURGICAL RECURRENCE IN PATIENTS WITH CROHN'S DISEASE

IBD (Posters)  et al.

CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME
CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

IBD (Posters)  et al.

PREDICTORS OF CLINICAL RESPONSE AND INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IMPROVEMENT WITH GOLIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS IN THE PURSUIT-MAINTENANCE STUDY
PREDICTORS OF CLINICAL RESPONSE AND INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IMPROVEMENT WITH GOLIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS IN THE PURSUIT-MAINTENANCE STUDY

IBD (Posters)  et al.

COMPARISON OF DAIRY FOODS INTOLERANCE BETWEEN INFLAMMATORY BOWEL DISEASE PATIENTS AND GENERAL POPULATION: A MULTINATIONAL CROSS SECTIONAL STUDY
COMPARISON OF DAIRY FOODS INTOLERANCE BETWEEN INFLAMMATORY BOWEL DISEASE PATIENTS AND GENERAL POPULATION: A MULTINATIONAL CROSS SECTIONAL STUDY

IBD (Posters)  et al.

INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU
INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU

IBD (Posters)  et al.

COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY
COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY

IBD (Posters)  et al.

IMPORTANCE OF IBD BIOPSY PROTOCOL IN CLINICAL PRACTICE: ANALYSES COMPARING TWO BRITISH PATIENTS’ COHORTS
IMPORTANCE OF IBD BIOPSY PROTOCOL IN CLINICAL PRACTICE: ANALYSES COMPARING TWO BRITISH PATIENTS’ COHORTS

IBD (Posters)  et al.

LONGITUDINAL DYNAMICS OF GUT MICROBIOME AND METABOLOME AFTER BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASES
LONGITUDINAL DYNAMICS OF GUT MICROBIOME AND METABOLOME AFTER BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY
EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

IBD (Posters)  et al.

PATIENT-REPORTED OUTCOMES OF RESPONSE AND REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT AS MEASURED BY THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY
PATIENT-REPORTED OUTCOMES OF RESPONSE AND REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT AS MEASURED BY THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

IBD (Posters)  et al.

INFLAMMATORY BOWEL DISEASE NEW-ONSET DURING SECUKINUMAB THERAPY: REAL-WORLD DATA FROM A TERCIARY CENTRE
INFLAMMATORY BOWEL DISEASE NEW-ONSET DURING SECUKINUMAB THERAPY: REAL-WORLD DATA FROM A TERCIARY CENTRE

IBD (Posters)  et al.

MISDIAGNOSIS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE – FINDINGS FROM A REAL-WORLD STUDY IN EUROPE
MISDIAGNOSIS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE – FINDINGS FROM A REAL-WORLD STUDY IN EUROPE

IBD (Posters)  et al.

CONCOMITANT USE OF STATINS IN FILGOTINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS
CONCOMITANT USE OF STATINS IN FILGOTINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS

IBD (Posters)  et al.

Item 301 - 320 / 568
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
16
17 18 19 20 21 22 23 24 25 26 27 28 29